LivaNova PLC (LIVN)
USD 37.48
(-5.11%)
USD 37.48
(-5.11%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 771.25 Million USD | 11.06% |
| 2022 | 707.2 Million USD | 0.17% |
| 2021 | 706 Million USD | 14.2% |
| 2020 | 618.2 Million USD | -17.0% |
| 2019 | 744.8 Million USD | 1.4% |
| 2018 | 734.5 Million USD | 12.72% |
| 2017 | 651.6 Million USD | -7.5% |
| 2016 | 704.4 Million USD | 166.57% |
| 2015 | 264.24 Million USD | 3.76% |
| 2014 | 254.65 Million USD | 9.57% |
| 2013 | 232.41 Million USD | 16.88% |
| 2012 | 198.84 Million USD | 18.75% |
| 2011 | 167.44 Million USD | 14.01% |
| 2010 | 146.86 Million USD | 18.86% |
| 2009 | 123.56 Million USD | 23.39% |
| 2008 | 100.13 Million USD | -11.15% |
| 2007 | 112.71 Million USD | 4.73% |
| 2006 | 107.61 Million USD | 22.48% |
| 2005 | 87.86 Million USD | -6.95% |
| 2004 | 94.42 Million USD | 6.82% |
| 2003 | 88.4 Million USD | 56.48% |
| 2002 | 56.49 Million USD | 0.0% |
| 2000 | 37.5 Million USD | 58.25% |
| 1999 | 23.7 Million USD | 102.56% |
| 1998 | 11.7 Million USD | 800.0% |
| 1997 | 1.3 Million USD | 8.33% |
| 1996 | 1.2 Million USD | 20.0% |
| 1995 | 1 Million USD | 66.67% |
| 1994 | 600 Thousand USD | 200.0% |
| 1993 | 200 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 210.59 Million USD | 10.72% |
| 2024 Q2 | 220.36 Million USD | 4.64% |
| 2024 Q3 | 225.26 Million USD | 2.22% |
| 2023 Q2 | 205.2 Million USD | 17.86% |
| 2023 Q3 | 201.8 Million USD | -1.66% |
| 2023 FY | 785.45 Million USD | 11.06% |
| 2023 Q4 | 190.2 Million USD | -5.75% |
| 2023 Q1 | 174.1 Million USD | -5.12% |
| 2022 FY | 707.2 Million USD | 0.17% |
| 2022 Q4 | 183.5 Million USD | 7.36% |
| 2022 Q3 | 170.91 Million USD | -7.31% |
| 2022 Q2 | 184.4 Million USD | 9.47% |
| 2022 Q1 | 168.44 Million USD | -16.49% |
| 2021 Q1 | 168.31 Million USD | -2.54% |
| 2021 Q2 | 173.68 Million USD | 3.19% |
| 2021 Q3 | 170.11 Million USD | -2.06% |
| 2021 Q4 | 201.7 Million USD | 18.57% |
| 2021 FY | 706 Million USD | 14.2% |
| 2020 Q3 | 152.48 Million USD | 25.84% |
| 2020 FY | 618.2 Million USD | -17.0% |
| 2020 Q2 | 121.17 Million USD | -29.55% |
| 2020 Q1 | 172 Million USD | -15.97% |
| 2020 Q4 | 172.7 Million USD | 13.26% |
| 2019 Q1 | 163.6 Million USD | -19.84% |
| 2019 Q2 | 197.11 Million USD | 20.49% |
| 2019 Q4 | 204.7 Million USD | 14.1% |
| 2019 Q3 | 179.4 Million USD | -8.98% |
| 2019 FY | 744.8 Million USD | 1.4% |
| 2018 Q1 | 162.1 Million USD | -5.81% |
| 2018 Q3 | 174.34 Million USD | -10.13% |
| 2018 Q4 | 204.1 Million USD | 17.06% |
| 2018 Q2 | 194 Million USD | 19.68% |
| 2018 FY | 734.5 Million USD | 12.72% |
| 2017 Q4 | 172.1 Million USD | -13.86% |
| 2017 FY | 651.6 Million USD | -7.5% |
| 2017 Q3 | 199.78 Million USD | -5.21% |
| 2017 Q2 | 210.77 Million USD | 14.28% |
| 2017 Q1 | 184.43 Million USD | 12.46% |
| 2016 Q4 | 164 Million USD | -13.14% |
| 2016 Q3 | 188.81 Million USD | -0.78% |
| 2016 FY | 704.4 Million USD | 166.57% |
| 2016 Q2 | 190.3 Million USD | 16.46% |
| 2016 Q1 | 163.4 Million USD | 0.0% |
| 2015 Q3 | 57.98 Million USD | -18.99% |
| 2015 FY | 264.24 Million USD | 3.76% |
| 2015 Q2 | 71.57 Million USD | 7.67% |
| 2015 Q1 | 66.47 Million USD | 1.45% |
| 2014 Q1 | 67.42 Million USD | 9.22% |
| 2014 Q2 | 65.59 Million USD | -2.72% |
| 2014 Q4 | 65.52 Million USD | -1.69% |
| 2014 Q3 | 66.65 Million USD | 1.61% |
| 2014 FY | 254.65 Million USD | 9.57% |
| 2013 Q3 | 63.17 Million USD | 1.36% |
| 2013 Q4 | 61.73 Million USD | -2.29% |
| 2013 Q1 | 61.98 Million USD | 8.11% |
| 2013 FY | 232.41 Million USD | 16.88% |
| 2013 Q2 | 62.32 Million USD | 0.55% |
| 2012 Q3 | 57.78 Million USD | 4.48% |
| 2012 Q1 | 53.13 Million USD | 5.35% |
| 2012 FY | 198.84 Million USD | 18.75% |
| 2012 Q4 | 57.33 Million USD | -0.78% |
| 2012 Q2 | 55.3 Million USD | 4.09% |
| 2011 Q3 | 49.53 Million USD | 8.3% |
| 2011 FY | 167.44 Million USD | 14.01% |
| 2011 Q4 | 50.43 Million USD | 1.82% |
| 2011 Q2 | 45.74 Million USD | 1.82% |
| 2011 Q1 | 44.92 Million USD | 8.84% |
| 2010 Q2 | 39.33 Million USD | -6.87% |
| 2010 Q1 | 42.23 Million USD | 17.76% |
| 2010 FY | 146.86 Million USD | 18.86% |
| 2010 Q3 | 41.91 Million USD | 6.54% |
| 2010 Q4 | 41.27 Million USD | -1.52% |
| 2009 Q1 | 33.46 Million USD | 10.35% |
| 2009 Q4 | 35.86 Million USD | 0.75% |
| 2009 FY | 123.56 Million USD | 23.39% |
| 2009 Q3 | 35.6 Million USD | 7.36% |
| 2009 Q2 | 33.16 Million USD | -0.91% |
| 2008 FY | 100.13 Million USD | -11.15% |
| 2008 Q2 | 28.91 Million USD | 3.28% |
| 2008 Q4 | 30.32 Million USD | -1.71% |
| 2008 Q1 | 27.99 Million USD | 15.48% |
| 2008 Q3 | 30.85 Million USD | 6.71% |
| 2007 Q2 | 23.52 Million USD | -8.49% |
| 2007 Q1 | 25.7 Million USD | -3.86% |
| 2007 Q3 | 24.37 Million USD | 3.6% |
| 2007 Q4 | 24.24 Million USD | -0.51% |
| 2007 FY | 112.71 Million USD | 4.73% |
| 2006 Q1 | 31.64 Million USD | 15.35% |
| 2006 Q4 | 26.73 Million USD | -11.87% |
| 2006 Q3 | 30.33 Million USD | 1.36% |
| 2006 FY | 107.61 Million USD | 22.48% |
| 2006 Q2 | 29.93 Million USD | -5.42% |
| 2005 FY | 87.86 Million USD | -6.95% |
| 2005 Q4 | 27.43 Million USD | 8.53% |
| 2005 Q3 | 25.27 Million USD | 8.69% |
| 2005 Q2 | 23.25 Million USD | -0.36% |
| 2005 Q1 | 23.34 Million USD | 3.93% |
| 2004 Q1 | 22.71 Million USD | -5.66% |
| 2004 Q2 | 20.36 Million USD | -10.35% |
| 2004 Q3 | 21.69 Million USD | 6.55% |
| 2004 FY | 94.42 Million USD | 6.82% |
| 2004 Q4 | 22.45 Million USD | 3.5% |
| 2003 Q2 | 22.68 Million USD | -4.08% |
| 2003 Q4 | 24.08 Million USD | -3.44% |
| 2003 FY | 88.4 Million USD | 56.48% |
| 2003 Q1 | 23.65 Million USD | 1.14% |
| 2003 Q3 | 24.93 Million USD | 9.92% |
| 2002 Q3 | 22.25 Million USD | 16.48% |
| 2002 Q4 | 23.38 Million USD | 5.09% |
| 2002 FY | 56.49 Million USD | 0.0% |
| 2002 Q2 | 19.1 Million USD | 13.41% |
| 2002 Q1 | 16.84 Million USD | 14.5% |
| 2001 Q3 | 13.42 Million USD | 16.72% |
| 2001 Q2 | 11.5 Million USD | 2.37% |
| 2001 Q4 | 14.71 Million USD | 9.55% |
| 2001 Q1 | 11.24 Million USD | -2.83% |
| 2000 Q2 | 10.9 Million USD | -2.07% |
| 2000 Q1 | 11.13 Million USD | 26.5% |
| 2000 FY | 37.5 Million USD | 58.25% |
| 2000 Q4 | 11.56 Million USD | 10.11% |
| 2000 Q3 | 10.5 Million USD | -3.63% |
| 1999 Q2 | 7.8 Million USD | 21.88% |
| 1999 Q1 | 6.4 Million USD | 18.52% |
| 1999 Q3 | 6.7 Million USD | -14.1% |
| 1999 Q4 | 8.8 Million USD | 31.34% |
| 1999 FY | 23.7 Million USD | 102.56% |
| 1998 FY | 11.7 Million USD | 800.0% |
| 1998 Q4 | 5.4 Million USD | 31.71% |
| 1998 Q3 | 4.1 Million USD | -8.89% |
| 1998 Q2 | 4.5 Million USD | 15.38% |
| 1998 Q1 | 3.9 Million USD | 56.0% |
| 1997 Q1 | 200 Thousand USD | -33.33% |
| 1997 FY | 1.3 Million USD | 8.33% |
| 1997 Q4 | 2.5 Million USD | 212.5% |
| 1997 Q3 | 800 Thousand USD | 60.0% |
| 1997 Q2 | 500 Thousand USD | 150.0% |
| 1996 Q1 | 300 Thousand USD | -25.0% |
| 1996 Q2 | 200 Thousand USD | -33.33% |
| 1996 Q3 | 300 Thousand USD | 50.0% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1996 FY | 1.2 Million USD | 20.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1995 Q1 | 300 Thousand USD | 50.0% |
| 1995 FY | 1 Million USD | 66.67% |
| 1995 Q3 | 200 Thousand USD | -50.0% |
| 1995 Q2 | 400 Thousand USD | 33.33% |
| 1994 Q4 | 200 Thousand USD | 100.0% |
| 1994 FY | 600 Thousand USD | 200.0% |
| 1994 Q1 | 200 Thousand USD | 0.0% |
| 1994 Q2 | 200 Thousand USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | -50.0% |
| 1993 FY | 200 Thousand USD | 0.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 Q4 | 200 Thousand USD | 0.0% |
| 1993 Q2 | -100 Thousand USD | -150.0% |
| 1993 Q3 | 200 Thousand USD | 300.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 24685.591% |
| Cerus Corporation | 86.4 Million USD | -792.65% |
| OrthoPediatrics Corp. | 111.25 Million USD | -593.24% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -104189.775% |
| Talis Biomedical Corporation | 371 Thousand USD | -207784.097% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -9224.749% |
| Inogen, Inc. | 126.69 Million USD | -508.726% |
| Spectral AI, Inc. | 7.88 Million USD | -9687.437% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 11799.788% |
| CVRx, Inc. | 33.03 Million USD | -2234.362% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -1264244.262% |
| Orthofix Medical Inc. | 486.27 Million USD | -58.604% |
| Venus Concept Inc. | 52.16 Million USD | -1378.425% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -30145.098% |
| Bioventus Inc. | 328.19 Million USD | -134.999% |
| BrainsWay Ltd. | 23.09 Million USD | -3240.046% |
| Envoy Medical, Inc. | -473 Thousand USD | 163154.968% |
| electroCore, Inc. | 13.22 Million USD | -5731.317% |
| IceCure Medical Ltd | 1.3 Million USD | -59226.923% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 12847.934% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1629409.616% |
| MaxCyte, Inc. | 36.54 Million USD | -2010.354% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -168842.23% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -906612.909% |
| PAVmed Inc | -3.96 Million USD | 19536.744% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 14161.076% |
| RxSight, Inc. | 53.76 Million USD | -1334.483% |
| Sight Sciences, Inc. | 69.17 Million USD | -1014.926% |
| SI-BONE, Inc. | 109.42 Million USD | -604.853% |
| TELA Bio, Inc. | 40.11 Million USD | -1822.741% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -4748.799% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -407.612% |
| 908 Devices Inc. | 25.32 Million USD | -2945.77% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -148.628% |
| Nemaura Medical Inc. | -1.47 Million USD | 52338.836% |
| NeuroPace, Inc. | 48.12 Million USD | -1502.697% |
| LENSAR, Inc. | 21.1 Million USD | -3554.001% |
| Apyx Medical Corporation | 14.12 Million USD | -5361.337% |
| Cutera, Inc. | 41.49 Million USD | -1758.702% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -4077.726% |
| BioSig Technologies, Inc. | 18 Thousand USD | -4284622.222% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -648.147% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -5565.124% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 13.186% |
| Axonics, Inc. | 274.55 Million USD | -180.91% |
| Outset Medical, Inc. | 29 Million USD | -2559.483% |
| IRIDEX Corporation | 21.8 Million USD | -3436.708% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -985.518% |
| IRadimed Corporation | 50.15 Million USD | -1437.633% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -268628.223% |
| INVO Bioscience, Inc. | 1.08 Million USD | -70908.472% |
| Telesis Bio, Inc. | 16.95 Million USD | -4450.147% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -583.835% |
| Varex Imaging Corporation | 256.9 Million USD | -200.214% |
| Quipt Home Medical Corp. | 163.84 Million USD | -370.719% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 190063.054% |
| Pulmonx Corporation | 50.75 Million USD | -1419.645% |
| Dynatronics Corporation | 7.63 Million USD | -10001.535% |
| Modular Medical, Inc. | -768 Thousand USD | 100523.177% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -13801.406% |
| Semler Scientific, Inc. | 61.2 Million USD | -1160.212% |
| InMode Ltd. | 411.34 Million USD | -87.497% |
| Bruker Corporation | 1.51 Billion USD | 49.153% |
| Cytosorbents Corporation | 22.39 Million USD | -3344.307% |
| DexCom, Inc. | 2.28 Billion USD | 66.305% |
| Align Technology, Inc. | 2.71 Billion USD | 71.632% |
| Viveve Medical, Inc. | 620 Thousand USD | -124295.161% |
| ZimVie Inc. | 290.38 Million USD | -165.598% |
| Movano Inc. | -158 Thousand USD | 488232.911% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -604.814% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -906612.909% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | -109.756% |
| Profound Medical Corp. | 4.51 Million USD | -16985.654% |
| Insulet Corporation | 1.15 Billion USD | 33.507% |
| enVVeno Medical Corporation | -546 Thousand USD | 141354.579% |
| Surmodics, Inc. | 93.05 Million USD | -728.838% |
| iCAD, Inc. | 14.53 Million USD | -5205.793% |
| Nuwellis, Inc. | 4.98 Million USD | -15377.624% |
| Biotricity, Inc. | 8.35 Million USD | -9129.584% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -132.44% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 214898.765% |
| InspireMD, Inc. | 1.8 Million USD | -42581.24% |
| PAVmed Inc. | -3.96 Million USD | 19536.744% |
| BIOLASE, Inc. | 16.72 Million USD | -4511.636% |
| Beyond Air, Inc. | -1.3 Million USD | 59109.181% |
| FONAR Corporation | 45.14 Million USD | -1608.572% |
| AxoGen, Inc. | 127.87 Million USD | -503.133% |
| Vivani Medical, Inc. | -357 Thousand USD | 216136.415% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -295.243% |
| Inari Medical, Inc. | 434.56 Million USD | -77.477% |
| UFP Technologies, Inc. | 112.22 Million USD | -587.235% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -6160535.834% |
| Tenon Medical, Inc. | 1.24 Million USD | -62047.462% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 952260.494% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -29257.589% |
| AdaptHealth Corp. | 479.56 Million USD | -60.823% |
| Sintx Technologies, Inc. | 1.84 Million USD | -41747.531% |
| NanoVibronix, Inc. | 1.53 Million USD | -50078.92% |
| Quanterix Corporation | 70.64 Million USD | -991.711% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 190063.054% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -5385.42% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -1361.254% |
| TransMedics Group, Inc. | 154.09 Million USD | -400.509% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -17219.784% |
| NeuroMetrix, Inc. | 3.94 Million USD | -19438.113% |
| Hyperfine, Inc. | 4.75 Million USD | -16112.949% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -620.949% |
| Biomerica, Inc. | 611 Thousand USD | -126127.496% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -1750.08% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 98857.291% |
| Silk Road Medical, Inc | 127.08 Million USD | -506.873% |